Weekly Summary Alert for Eli Lilly and Company

Eli Lilly and sent this email to their subscribers on November 16, 2024.

Eli Lilly and Company added the following items during the week of November 11, 2024

Product News

Treatment with tirzepatide in adults with pre-diabetes and obesity or overweight resulted in sustained weight loss and nearly 99% remained diabetes-free at 176 weeks

All SEC Filings

SC 13G/A

Insider Transactions

SC 13G/A

LLY	Monday	Tuesday	Wednesday	Thursday	Friday
Opening Price	$831.30	$830.20	$820.32	$809.19	$775.19
Last Trade	$832.44	$818.86	$811.81	$786.23	$746.20
Price Change	+$0.90	-$13.58	-$7.05	-$25.58	-$40.03
Percent Change	+0.11%	-1.63%	-0.86%	-3.15%	-5.09%
Day High	$844.00	$833.99	$829.11	$809.19	$777.98
Day Low	$824.63	$810.72	$811.29	$783.51	$744.20
Volume	3,341,336	3,376,860	3,058,570	3,996,056	7,298,826

Visit the website →

Text-only version of this email

Eli Lilly and Company Eli Lilly and Company added the following items during the week of November 11, 2024 PRODUCT NEWS Treatment with tirzepatide in adults with pre-diabetes and obesity or overweight resulted in sustained weight loss and nearly 99% remained diabetes-free at 176 weeks ALL SEC FILINGS SC 13G/A INSIDER TRANSACTIONS SC 13G/A LLYMondayTuesdayWednesdayThursdayFridayOpening Price$831.30$830.20$820.32$809.19$775.19Last Trade$832.44$818.86$811.81$786.23$746.20Price Change+$0.90-$13.58-$7.05-$25.58-$40.03Percent Change+0.11%-1.63%-0.86%-3.15%-5.09%Day High$844.00$833.99$829.11$809.19$777.98Day Low$824.63$810.72$811.29$783.51$744.20Volume3,341,3363,376,8603,058,5703,996,0567,298,826 Visit the website →

Show all